PDB15 COMPARATIVE COST-UTILITY ANALYSIS OF LONG-ACTING INSULIN ANALOGUE (INSULIN DETEMIR) AND NPH INSULIN FOR THE TREATMENT OF TYPE 1 AND TYPE 2 DIABETES AND THE BUDGET IMPACT ANALYSIS OF INSULIN ANALOGUE REIMBURSEMENT IN POLAND
Nov 1, 2008, 00:00 AM
10.1016/S1098-3015(10)66662-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)66662-4/fulltext
Section Title :
Section Order :
497
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66662-4&doi=10.1016/S1098-3015(10)66662-4